Startup profile · funding coverage
Nourish funding, valuation and investors
Virtual dietitian-led metabolic health clinic — licensed clinicians, not wellness content.
Keep track of Nourish
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$100M · May 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$100M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York
Overview
Nourish operates what it describes as the country's largest dietitian-led metabolic health clinic, delivering virtual nutrition care with licensed professionals for conditions including diabetes and GLP-1 coordination. The New York company raised $100M Series C in May 2026, bringing total funding to $215M per VC News Daily. Investors want care models employers and payers can credential with documented clinical outcomes.
Why Nourish is interesting
Nourish's $100M Series C ($215M total) validates payer-credible clinical models in metabolic health as GLP-1 and employer wellness budgets converge — clinicians show up, not chatbots.
Product & use cases
Virtual metabolic health clinic staffed by licensed dietitians — telehealth nutrition care with outcomes tracking for chronic conditions.
- Diabetes and metabolic condition nutrition management
- GLP-1 patient nutrition coordination
- Employer and payer-contracted virtual dietitian care
Key facts
- Series C (May 2026): $100M; $215M total funding (VC News Daily)
- Largest dietitian-led metabolic health clinic positioning
- NYC virtual clinical care model
- GLP-1 and chronic condition nutrition focus
Funding history (newest first)
Series C
2026-05 $100MSource: Read source · vcnewsdaily.com
Competitive landscape
Edge: Licensed-clinician-led model with scale — credentialing-friendly for payers vs. generic wellness apps.
Metabolic health is crowded post-GLP-1 boom. Nourish wins on dietitian credentialing and outcomes data for payer contracts; reimbursement and clinical validation are gating factors.
-
Omada Health direct
Chronic condition digital care; overlapping employer channel.
-
Noom adjacent
Weight/metabolic consumer app; less clinician-led.
-
Teladoc adjacent
Virtual care incumbent; broader telehealth scope.
Notable stories
- $100M Series C rewards licensed-clinician models over wellness wrappers.
- Metabolic health converges GLP-1 coordination, diabetes prevention, employer spend.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Nourish's financing or category context.
FAQs about Nourish
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.